Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
20.1%Inventory to Assets Ratio
VS
Market
Sector
Industry
History
$ 9.34Close
$ 2.9 - $ 9.34 52-Week Range
Ticker Information
Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXERIS BIOPHARMA HOLDINGS INC - Inventory to Assets Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XERS - Inv. to Assets Historical data
| Date | Total Assets | Inventory | Inventory to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 334.69M | $ 67.28M | 20.1% |
| 3/31/2025 | $ 315.45M | $ 52.69M | 16.7% |
| 12/31/2024 | $ 323.06M | $ 48.17M | 14.91% |
| 9/30/2024 | $ 321.1M | $ 45.12M | 14.05% |
| 6/30/2024 | $ 331.73M | $ 42.98M | 12.96% |
| 3/31/2024 | $ 336.62M | $ 40.88M | 12.14% |
| 12/31/2023 | $ 322.6M | $ 38.84M | 12.04% |
| 9/30/2023 | $ 327.78M | $ 38.14M | 11.64% |
| 6/30/2023 | $ 328.78M | $ 36.54M | 11.11% |
| 3/31/2023 | $ 321.36M | $ 29.04M | 9.04% |
Key Performance Insights, Last 5 Years
- XERIS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) Inv. to Assets stands at 3.31%.
- Over the past 5 years, XERIS BIOPHARMA HOLDINGS INC's average Inv. to Assets has been 10%.
- The median Inv. to Assets for XERIS BIOPHARMA HOLDINGS INC during this period was 9.94%
- XERIS BIOPHARMA HOLDINGS INC reached its highest Inv. to Assets over the past 5 years at 20.1%.
- The lowest Inv. to Assets recorded by XERIS BIOPHARMA HOLDINGS INC in the same timeframe 3.31%
XERIS BIOPHARMA HOLDINGS INC's Inv. to Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inv. to Assets Benchmarks
Similar metrics to Inv. to Assets:
- Inventory - [Balance Sheet] Inventory is a component of [Assets] that represents the expected market value of inventories in all stages of completion.
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
Definition of Inventory to Assets Ratio
[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.Inventory / Assets
(=) Inv. to Assets Inv. to Assets for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: Inventory [ $ 5.63M ] / Assets [ $ 170.39M ]
(=) Inv. to Assets [ 3.31% ] XERS - Inventory to Assets Ratio, Last 5 years
3.31%
Minimum
Sep 30, 2020
20.1%
Maximum
Jun 30, 2025
10%
Average
9.94%
Median
Inv. to Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
| filtered constituents | 4.46K |
|---|---|
| min | 0% |
| max | 98.39% |
| average | 6.08% |
| median | 0% |
| std | 11.11% |